Search Results 931-940 of 15289 for alt

1. A Study of ONO-7475 in Patients With Acute Leukemias - Mayo Clinic

   AST and ALT ≤ 2.5 x ULN;; Calculated creatinine clearance ≥ 45 mL/min.;; Serum albumin ≥ 2.5 g/dL. For any patient with laboratory values outside the ...

2. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 1.5 x institutional upper limit of normal (ULN) - Creatinine =< institutional upper limit of normal ...

3. A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors - Mayo Clinic

   Alanine aminotransferase (ALT) and (aspartate aminotransferase) AST ≤ 3x institutional upper limit of normal (ULN); Total bilirubin ≤ 1.5x institutional ...

4. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   ... (ALT) ≤ 3 x ULN or SGOT (AST) ≤ 5 x ULN in the presences of hepatic metastasis; Creatinine ≤ 1.5 x ULN; International normalized ratio (INR) ≤ 1.4 unless ...

5. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 110 units per liter (U/L); for the purpose of this study, the ULN for SGPT is ...

6. PC945 Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients - Mayo Clinic

   Subject with an elevated alanine transaminase (ALT) or, aspartate transaminase (AST) > 5 x the upper limit of normal (ULN). 10. Subject with any known ...

7. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) ≤ 3 x ULN; Serum albumin ≥ 2.8 g/dL; Lipase ≤ 2.0 x ULN and no radiologic or clinical evidence of ...

8. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

   days of screening. - AST and ALT ≤ 3.0 x upper limit of normal (ULN) - Total bilirubin ≤ 1.5 x ULN. - Creatinine clearance of ≥ 30 mL/min according to ...

9. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

   AST (SGOT) or ALT (SGPT) < 3 x institutional ULN. Ability to complete questionnaire(s) by themselves or with assistance. Able to provide written informed ...

10. A Study To Evaluate The Effect Of GBT440 On Oxygenation In Healthy Subjects, Both At Rest And At Maximal Exercise - Mayo Clinic

    AST, ALT or total bilirubin >2 × ULN; Serum creatinine >1.5 mg/dL; Clinical evidence of active infection, within 21 days of screening, which may include but ...